HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qiaohong Wang Selected Research

Cardiomegaly (Heart Hypertrophy)

9/2008Transgenic overexpression of Hdac3 in the heart produces increased postnatal cardiac myocyte proliferation but does not induce hypertrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qiaohong Wang Research Topics

Disease

5Neoplasms (Cancer)
01/2022 - 05/2017
2Parkinson Disease (Parkinson's Disease)
01/2023 - 10/2004
1Critical Illness (Critically Ill)
05/2024
1Lentivirus Infections
01/2024
1Atopic Dermatitis (Atopic Eczema)
11/2023
1Autoimmune Diseases (Autoimmune Disease)
01/2023
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2023
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2023
1Insulin Resistance
12/2022
1Rheumatoid Arthritis
12/2022
1Colorectal Neoplasms (Colorectal Cancer)
01/2022
1Carcinogenesis
01/2022
1Thrombosis (Thrombus)
11/2021
1Pruritus (Itching)
10/2021
1Hypersensitivity (Allergy)
10/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021
1Laminopathies
01/2021
1Heart Failure
12/2020
1Pregnancy Complications
12/2020
1Hypoxia (Hypoxemia)
09/2020
1Ovarian Neoplasms (Ovarian Cancer)
11/2017
1Cardiomegaly (Heart Hypertrophy)
09/2008
1Mitochondrial Diseases (Mitochondrial Disease)
02/2003
1Neurodegenerative Diseases (Neurodegenerative Disease)
02/2003

Drug/Important Bio-Agent (IBA)

3Immune Checkpoint InhibitorsIBA
09/2020 - 05/2017
2RNA (Ribonucleic Acid)IBA
01/2022 - 09/2020
2Proteins (Proteins, Gene)FDA Link
12/2020 - 10/2004
1Small Interfering RNA (siRNA)IBA
01/2024
1mesoglycanIBA
11/2023
1Methotrexate (Mexate)FDA LinkGeneric
11/2023
1Prothrombin (Factor II)IBA
01/2023
1Rituximab (Mabthera)FDA Link
01/2023
1AntibodiesIBA
01/2023
1Immunoglobulin M (IgM)IBA
01/2023
1LipidsIBA
12/2022
1Complement System Proteins (Complement)IBA
01/2022
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
11/2021
1AntithrombinsIBA
11/2021
1Warfarin (Coumadin)FDA LinkGeneric
11/2021
1Nadroparin (Nadroparin Calcium)IBA
10/2021
1Enoxaparin (Lovenox)FDA LinkGeneric
10/2021
1Dalteparin (Dalteparin Sodium)FDA Link
10/2021
1plumbaginIBA
01/2021
1Lamin Type A (Lamin A)IBA
01/2021
1Lysine (L-Lysine)FDA Link
12/2020
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
12/2020
1Messenger RNA (mRNA)IBA
09/2020
1apatinibIBA
09/2020
1LigandsIBA
11/2017
1Isoproterenol (Isoprenaline)FDA LinkGeneric
09/2008
1alpha-SynucleinIBA
10/2004
1alvocidib (flavopiridol)IBA
02/2003
1Proteasome Endopeptidase Complex (Proteasome)IBA
02/2003
1Cyclin-Dependent Kinases (cdk Proteins)IBA
02/2003
1lactacystinIBA
02/2003

Therapy/Procedure

4Therapeutics
11/2023 - 09/2020
2Immunotherapy
05/2018 - 05/2017
1Continuous Renal Replacement Therapy
05/2024
1Remission Induction
01/2023
1Palliative Care (Palliative Therapy)
01/2023